AllianceBernstein
NPCE icon

AllianceBernstein’s Neuropace NPCE Stock Holding History

AllianceBernstein’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$180K Buy
+13,710
New +$221K ﹤0.01% 3177
2025
Q4 		– Sell
-11,310
Closed -$117K – 3278
2025
Q3 		$117K Hold
11,310
– – ﹤0.01% 3169
2025
Q2 		$126K Buy
+11,310
New +$141K ﹤0.01% 3139

Other funds holding NPCE

Polar Capital Holdings
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
Soleus Capital Management
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
First Light Asset Management
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Driehaus Capital Management
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Armistice Capital
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

AllianceBernstein's NPCE Position: Q2 2026 in Review

AllianceBernstein opened a new position in Neuropace (NPCE) in Q2 2026: 13,710 shares worth $180K. The stake represents ﹤0.01% of the portfolio and ranks #3177 among its holdings. This is a return to the name: AllianceBernstein previously reported a position in NPCE as recently as Q3 2025.

AllianceBernstein first reported a position in NPCE in Q2 2025 and has held it in 3 quarters since. 112 funds tracked by Wall St. Rank hold NPCE as of Q2 2026.

  • AllianceBernstein held 13,710 shares of Neuropace worth $180K as of Q2 2026.
  • Neuropace was a new AllianceBernstein position in Q2 2026.
  • Neuropace made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #3177 holding.
  • AllianceBernstein first reported a position in Neuropace in Q2 2025 and has held it in 3 quarters since.
  • 112 funds tracked by Wall St. Rank held Neuropace as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.